Quintiles Transnational Holdings Inc (NYSE:Q)

Data as of Oct 24
 +0.57 / +1.00%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

Quintiles Transnational Holdings, Inc. provides biopharmaceutical development services and commercial outsourcing services. The company operates through two business segments: Product Development and Integrated Healthcare Services. The Product Development segment provides services and expertise that allow biopharmaceutical companies to outsource the clinical development process from first in man trials to post-launch monitoring. Its comprehensive service provides the support and functional expertise necessary at each stage of development, as well as the systems and analytical capabilities to help its customers improve product development efficiency and effectiveness. The Product Development segment is comprised of clinical solutions and services and consulting. Clinical solutions and services provides services necessary to develop biopharmaceutical products, including project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV) and clinical trial support services that improve clinical trial decision making and include global laboratories, data management, biostatistical, safety and pharmacovigilance, and early clinical development trials, and strategic planning and design services that improve decisions and performance. Consulting provides strategy and management consulting services based on life science expertise and advanced analytics, as well as regulatory and compliance consulting services. The Integrated Healthcare Services provides the healthcare industry with both broad geographic presence and commercial capabilities. It provides a broad array of services, including commercial services, such as providing contract pharmaceutical sales forces in key geographic markets, as well as a growing number of healthcare business services for the broader healthcare sector. The company was founded in December 2009 and is headquartered in Durham, NC.

Contact Information

Quintiles Transnational Holdings, Inc.
4820 Emperor Boulevard
Durham North Carolina 27703
P:(919) 998-2000
Investor Relations:



Individual stakeholders51.96%
Other institutional26.12%
Mutual fund holders21.88%

Top Executives

Thomas H. PikeChief Executive Officer & Director
Kevin K. GordonChief Financial Officer & Executive Vice President
James H. ErlingerSecretary, Executive VP & General Counsel
Derek M. WinstanlyExecutive VP, Chief Customer & Governance Officer
Charles Edward WilliamsSenior Vice President & Controller

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.